294 related articles for article (PubMed ID: 28540777)
21. Cytoreductive Surgery and HIPEC in an Enhanced Recovery After Surgery Program: A Feasibility Study.
Lu PW; Fields AC; Shabat G; Bleday R; Goldberg JE; Irani J; Stopfkuchen-Evans M; Melnitchouk N
J Surg Res; 2020 Mar; 247():59-65. PubMed ID: 31767280
[TBL] [Abstract][Full Text] [Related]
22. High-grade complication is associated with poor overall survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Tan JW; Tan GHC; Ng WY; Ong CJ; Chia CS; Soo KC; Teo MCC
Int J Clin Oncol; 2020 May; 25(5):984-994. PubMed ID: 31915944
[TBL] [Abstract][Full Text] [Related]
23. Colorectal peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: the experience of a tertiary Asian center.
Teo MC; Ching Tan GH; Lim C; Chia CS; Tham CK; Soo KC
Asian J Surg; 2015 Apr; 38(2):65-73. PubMed ID: 25059814
[TBL] [Abstract][Full Text] [Related]
24. Hospital readmission rates and risk factors for readmission following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal surface malignancies.
Dreznik Y; Hoffman A; Hamburger T; Ben-Yaacov A; Dux Y; Jacoby H; Berger Y; Nissan A; Gutman M
Surgeon; 2018 Oct; 16(5):278-282. PubMed ID: 29429947
[TBL] [Abstract][Full Text] [Related]
25. Ninety-day post-operative morbidity and mortality using the National Cancer Institute's common terminology criteria for adverse events better describe post-operative outcome after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Alyami M; Kim BJ; Villeneuve L; Vaudoyer D; Képénékian V; Bakrin N; Gilly FN; Cotte E; Glehen O; Passot G
Int J Hyperthermia; 2018 Aug; 34(5):532-537. PubMed ID: 28838265
[TBL] [Abstract][Full Text] [Related]
26. Cytoreduction (Peritonectomy Procedures) Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Advanced Ovarian Cancer: Retrospective Italian Multicenter Observational Study of 511 Cases.
Di Giorgio A; De Iaco P; De Simone M; Garofalo A; Scambia G; Pinna AD; Verdecchia GM; Ansaloni L; Macrì A; Cappellini P; Ceriani V; Giorda G; Biacchi D; Vaira M; Valle M; Sammartino P
Ann Surg Oncol; 2017 Apr; 24(4):914-922. PubMed ID: 27896512
[TBL] [Abstract][Full Text] [Related]
27. Infectious Complications after Cytoreductive Surgery and Hyperthermic Intra-Peritoneal Chemotherapy.
Arslan NC; Sokmen S; Avkan-Oguz V; Obuz F; Canda AE; Terzi C; Fuzun M
Surg Infect (Larchmt); 2017; 18(2):157-163. PubMed ID: 27906610
[TBL] [Abstract][Full Text] [Related]
28. Routine ureteric stenting before cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in managing peritoneal carcinomatosis from gynecologic malignancies: a single-center experience.
Abu-Zaid A; Abou Al-Shaar H; Azzam A; AlOmar O; Al-Otaibi MF; Amin T; Al-Badawi IA
Ir J Med Sci; 2017 May; 186(2):269-273. PubMed ID: 27052968
[TBL] [Abstract][Full Text] [Related]
29. Peritonectomy and hyperthermic chemotherapy in patients with advanced or recurrent ephitelial ovarian cancer: a single center cohort study.
Massari R; Barone M; Basilico R; Carella C; Colasante A; De Tursi M; Filippone A; Guetti L; Mani A
Minerva Chir; 2014 Feb; 69(1):17-26. PubMed ID: 24675243
[TBL] [Abstract][Full Text] [Related]
30. Routine second-look after surgical treatment of colonic peritoneal carcinomatosis.
Delhorme JB; Triki E; Romain B; Meyer N; Rohr S; Brigand C
J Visc Surg; 2015 Jun; 152(3):149-54. PubMed ID: 25650364
[TBL] [Abstract][Full Text] [Related]
31. Treatment of ovarian metastases of colorectal and appendiceal carcinoma in the era of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Kuijpers AM; Mehta AM; Aalbers AG; van Driel WJ; Boot H; Verwaal VJ
Eur J Surg Oncol; 2014 Aug; 40(8):937-42. PubMed ID: 24630923
[TBL] [Abstract][Full Text] [Related]
32. "Assessment of RIFLE and AKIN criteria to define acute renal dysfunction for HIPEC procedures for ovarian and non ovarian peritoneal malignances".
Arjona-Sánchez A; Cadenas-Febres A; Cabrera-Bermon J; Muñoz-Casares FC; Casado-Adam A; Sánchez-Hidalgo JM; López-Andreu M; Briceño-Delgado J; Rufián-Peña S
Eur J Surg Oncol; 2016 Jun; 42(6):869-76. PubMed ID: 26898841
[TBL] [Abstract][Full Text] [Related]
33. Anesthesia and Pain Management for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Desmoplastic Small Round Cell Tumors in Children, Adolescents, and Young Adults.
Anghelescu DL; Brown CL; Murphy AJ; Davidoff AM; Dickson PV; Glazer ES; Stiles ZE; Bishop MW; Douthitt L; Deneve JL
Ann Surg Oncol; 2019 Jan; 26(1):131-138. PubMed ID: 30353396
[TBL] [Abstract][Full Text] [Related]
34. Delayed presentation of major complications in patients undergoing cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy following hospital discharge.
Bhagwandin SB; Naffouje S; Salti G
J Surg Oncol; 2015 Mar; 111(3):324-7. PubMed ID: 25557653
[TBL] [Abstract][Full Text] [Related]
35. Serious Postoperative Complications Affect Early Recurrence After Cytoreductive Surgery and HIPEC for Colorectal Peritoneal Carcinomatosis.
Simkens GA; van Oudheusden TR; Luyer MD; Nienhuijs SW; Nieuwenhuijzen GA; Rutten HJ; de Hingh IH
Ann Surg Oncol; 2015 Aug; 22(8):2656-62. PubMed ID: 25515200
[TBL] [Abstract][Full Text] [Related]
36. Identification of risk factors associated with postoperative acute kidney injury after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a retrospective study.
Cata JP; Zavala AM; Van Meter A; Williams UU; Soliz J; Hernandez M; Owusu-Agyemang P
Int J Hyperthermia; 2018 Aug; 34(5):538-544. PubMed ID: 28812384
[TBL] [Abstract][Full Text] [Related]
37. Hyperthermic intraperitoneal chemotherapy with cisplatin: Amifostine prevents acute severe renal impairment.
Bouhadjari N; Gabato W; Calabrese D; Msika S; Keita H
Eur J Surg Oncol; 2016 Feb; 42(2):219-23. PubMed ID: 26278017
[TBL] [Abstract][Full Text] [Related]
38. Trends in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of synchronous peritoneal carcinomatosis of colorectal origin in the Netherlands.
Razenberg LG; van Gestel YR; Creemers GJ; Verwaal VJ; Lemmens VE; de Hingh IH
Eur J Surg Oncol; 2015 Apr; 41(4):466-71. PubMed ID: 25680955
[TBL] [Abstract][Full Text] [Related]
39. Iterative procedures combining cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for isolated peritoneal recurrence.
Vaira M; Robella M; Mellano A; Sottile A; De Simone M
Int J Hyperthermia; 2014 Dec; 30(8):565-9. PubMed ID: 25430988
[TBL] [Abstract][Full Text] [Related]
40. Hyperthermic intraperitoneal chemotherapy with oxaliplatin and without adjuvant chemotherapy in stage IIIC ovarian cancer.
Carrabin N; Mithieux F; Meeus P; Trédan O; Guastalla JP; Bachelot T; Labidi SI; Treilleux I; Rivoire M; Ray-Coquard I
Bull Cancer; 2010 Apr; 97(4):E23-32. PubMed ID: 20202920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
